FibroBiologics Inc. Commo...

NASDAQ: FBLG · Real-Time Price · USD
0.65
-0.06 (-8.71%)
At close: Jun 27, 2025, 3:59 PM
0.65
0.78%
After-hours: Jun 27, 2025, 05:52 PM EDT

FibroBiologics Common Stock Statistics

Share Statistics

FibroBiologics Common Stock has 38.26M shares outstanding. The number of shares has increased by 11.28% in one year.

38.26M
11.28%
5.05%
16.01%
27.42M
4,195
1.66%

Short Selling Information

The latest short interest is 1.35M, so 3.43% of the outstanding shares have been sold short.

1.35M
3.43%
4.06%
4.17

Valuation Ratios

The PE ratio is -5.89 and the forward PE ratio is -1.52. FibroBiologics Common Stock's PEG ratio is 0.14.

-5.89
-1.52
0
0.8
24.04
-5.44
0.14
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for FibroBiologics Common Stock.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 3.86.

1.12
1.12
3.86
-0.77
-0.87
-686.85

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-858,538.46
13
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -86.97% in the last 52 weeks. The beta is -0.78, so FibroBiologics Common Stock's price volatility has been lower than the market average.

-0.78
-86.97%
0.91
1.8
31.27
253,001

Income Statement

n/a
n/a
-13.74M
-11.16M
-13.74M
-11.18M
-0.34
Full Income Statement

Balance Sheet

The company has 13.98M in cash and 10.55M in debt, giving a net cash position of 3.43M.

13.98M
10.55M
3.43M
-35.52M
11.43M
1.12M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.9M and capital expenditures -184K, giving a free cash flow of -12.09M.

-11.9M
-184K
-12.09M
-0.37
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

FBLG does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for FBLG is $12, which is 1746.2% higher than the current price. The consensus rating is "Buy".

$12
1746.2%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-4.97
1